1887

Journal of General Virology header logo

Volume 89, Issue 7

Use of synthetic peptides to represent surface-exposed epitopes defined by neutralizing dengue complex- and flavivirus group-reactive monoclonal antibodies on the native dengue type-2 virus envelope glycoprotein Free

Abstract

The reactions of neutralizing monoclonal antibodies (mAbs) that defined dengue virus (DENV) complex, flavivirus subgroup or group neutralizing epitopes were tested against synthetic peptide sequences from domains I, II and III of the envelope (E) glycoproteins of different DENV-2 genotypes/strains. The DENV complex-reactive mAb identified the surface-exposed 304-GKFKV/IVKEIA-313 peptides and the DENV complex-conserved 393-KKGSSIGQ/KM-401 peptides in domain III, which were located adjacently in the native glycoprotein. Both flavivirus group-reactive mAbs reacted most strongly with fusion sequence peptides from domain II when they contained a cysteine (C) by glycine (G) substitution (underlined) (101-WGNGGLFG-109) to represent the native rotated C side chain. The 393–401 sequence represents a newly identified epitope, present as a highly flexible coil located between the 385 and 393 cell-binding sequence and the 401 and 413 sequence involved in the E glycoprotein homo-trimer formation. The 101–109 sequence containing 105-C by G substitution and the 393–401 sequence are good candidates for diagnostic assays and cross-protection experiments.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.83648-0
2008-07-01
2024-04-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/89/7/1616.html?itemId=/content/journal/jgv/10.1099/vir.0.83648-0&mimeType=html&fmt=ahah

References

  1. Aaskov J. G., Geysen H. M., Mason T. J. 1989; Serological defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409. Arch Virol 105:209–221 [CrossRef]
     [Google Scholar]
  2. Allison S. L., Stiasny K., Stadler K., Mandl C. W., Heinz F. X. 1999; Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. J Virol 73:5605–5612
     [Google Scholar]
  3. Allison S. L., Schalich J., Stiasny K., Mandl C. W., Heinz F. X. 2001; Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol 75:4268–4275 [CrossRef]
     [Google Scholar]
  4. Cologna R., Rico-Hesse R. 2003; American genotype structures decrease dengue virus output from human monocytes and dendritic cells. J Virol 77:3929–3938 [CrossRef]
     [Google Scholar]
  5. Crill W. D., Chang G. J. 2004; Localization and characterisation of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 78:13975–13986 [CrossRef]
     [Google Scholar]
  6. Crill W. D., Roehrig J. T. 2001; Monoclonal antibodies that bind to domain III of the dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol 75:7769–7773 [CrossRef]
     [Google Scholar]
  7. Crill W. D., Trainor N. B., Chang G. J. 2007; A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol 88:1169–1174 [CrossRef]
     [Google Scholar]
  8. Falconar A. K. I. 1997; The dengue virus non-structural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesion proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142:897–916 [CrossRef]
     [Google Scholar]
  9. Falconar A. K. I. 1999; Identification of an epitope on the dengue virus membrane (M) protein defined by cross-reactive monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. Arch Virol 144:2313–2330 [CrossRef]
     [Google Scholar]
  10. Falconar A. K. I. 2007; Antibody responses to immunodominant ELK/KLE-type motifs on the dengue virus non-structural-1 glycoprotein during live dengue virus infections in mice and humans: implications for diagnosis, pathogenesis, and vaccine design. Clin Vaccine Immunol 14:493–504 [CrossRef]
     [Google Scholar]
  11. Falconar A. K. I., Young P. R. 1991; Production of dimer-specific and dengue virus group cross-reactive mouse monoclonal antibodies to the dengue 2 non-structural glycoprotein NS1. J Gen Virol 72:961–965 [CrossRef]
     [Google Scholar]
  12. Falconar A. K. I., Young P. R., Miles M. A. 1994; Precise location of sequential dengue virus subcomplex and complex B cell epitopes on the nonstructural-1 glycoprotein. Arch Virol 137:315–326 [CrossRef]
     [Google Scholar]
  13. Goncalvez A. P., Purcell R. H., Lai C. J. 2004; Epitope determinants of a chimpanzee Fab fragment that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside an in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. J Virol 78:12919–12928 [CrossRef]
     [Google Scholar]
  14. Goncalvez A. P., Engle R. E., St Claire M., Purcell R. H., Lai C. J. 2007; Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci U S A 104:9422–9427 [CrossRef]
     [Google Scholar]
  15. Gubler D. J. 2006; Dengue/dengue haemorrhagic fever: history and current status. Novartis Found Symp 277:3–16
     [Google Scholar]
  16. Henchal E. A., McCowan J. M., Burke D. S., Seguin M. C., Brandt W. E. 1985; Epitope analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg 34:162–169
     [Google Scholar]
  17. Holmes E. C. 2006; The evolutionary biology of dengue virus. Novartis Found Symp 277:177–187
     [Google Scholar]
  18. Lewis J. A., Chang G., Lanciotti R. S., Kinney R. M., Mayer L. W., Trent D. W. 1993; Phylogenetic relationships of dengue-2 viruses. Virology 197:216–224 [CrossRef]
     [Google Scholar]
  19. Lin B., Parish C. R., Murray J. M., Aaskov J. 1994; Localization of a neutralizing epitope on the envelope protein of dengue virus type 2. Virology 202:885–890 [CrossRef]
     [Google Scholar]
  20. Megret F., Hugnot J. P., Falconar A. K. I., Gentry M. K., Morens D. W., Murray J. M., Schlesinger J. J., Wright P. J., Young P.R. other authors 1992; Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology 187:480–491 [CrossRef]
     [Google Scholar]
  21. Modis Y., Ogata S., Clements D., Harrison S. C. 2003; A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci U S A 100:6986–6991 [CrossRef]
     [Google Scholar]
  22. Modis Y., Ogata S., Clements D., Harrison S. C. 2004; Structure of the dengue virus envelope protein after membrane fusion. Nature 427:313–319 [CrossRef]
     [Google Scholar]
  23. Oliphant T., Nybakken G. E., Engle E., Xu Q., Nelson C. A., Sukupolvi-Petty S., Marri A., Lachmi B. E., Olshevsky U. other authors 2006; Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein. J Virol 80:12149–12159 [CrossRef]
     [Google Scholar]
  24. Roehrig J. T., Johnson A. J., Hunt A. R., Bolin R. A., Chu M. C. 1990; Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology 177:668–675 [CrossRef]
     [Google Scholar]
  25. Stiasny K., Kiermayr S., Holzmann H., Heinz F. X. 2006; Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J Virol 80:9557–9568 [CrossRef]
     [Google Scholar]
  26. Sukupolvi-Petty S., Austin S. K., Purtha W. E., Oliphant T., Nybakken G. E., Schlesinger J. J., Roehrig J. T., Gromowski G. D., Barrett A. D. other authors 2007; Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognise adjacent epitopes. J Virol 81:12816–12826 [CrossRef]
     [Google Scholar]
  27. Trainor N. B., Crill W. D., Robertson J. A., Chang G. J. 2007; Mutation analysis of the fusion domain region of St Louis encephalitis virus envelope protein. Virology 360:398–406 [CrossRef]
     [Google Scholar]
  28. Zhang W., Chipman P. R., Corver J., Johnson P. R., Zhang Y., Mukhopadhyay S., Baker T. S., Strauss J. H., Rossmann M. G., Kuhn R. J. 2003; Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 10:907–912 [CrossRef]
     [Google Scholar]
  29. Zhang Y., Zhang W., Ogata S., Clements D., Strauss J. H., Baker T. S., Kuhn R. J., Rossmann M. G. 2004; Conformational changes of the flavivirus E glycoprotein. Structure 12:1607–1618 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.83648-0
Loading
Use of synthetic peptides to represent surface-exposed epitopes defined by neutralizing dengue complex- and flavivirus group-reactive monoclonal antibodies on the native dengue type-2 virus envelope glycoprotein
J. Gen. Virol. 89, 1616 (2008); https://doi.org/10.1099/vir.0.83648-0
/content/journal/jgv/10.1099/vir.0.83648-0
/content/journal/jgv/10.1099/vir.0.83648-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error